PANDORA INVESTMENTS PUBLIC LIMITED financials
PANDORA INVESTMENTS PUBLIC LIMITED
Country: CY Reporting currency: EUR Latest annual report: 2021-12-31
LEI:
213800HHBJ4IUJS6VP21 Financial statements
(EUR, as reported — unscaled; 104 line items across 2 annual periods)
| Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Revenue | €64.5M | €65.6M |
| Cost of sales | €36.0M | €31.4M |
| Gross profit | €28.5M | €34.2M |
| Other income | €2.0M | €2.9M |
| Administrative expenses | €14.0M | €11.8M |
| Operating profit (EBIT) | €25.2M | €16.6M |
| Finance costs | €5.9M | €4.9M |
| Profit before tax | €17.8M | €10.7M |
| Income tax expense | €430.9K | €158.7K |
| Profit for the year | €17.4M | €10.6M |
| — attributable to owners | €17.3M | €10.2M |
| — attributable to NCI | €68.1K | €334.6K |
| Total comprehensive income | €17.1M | €10.1M |
| Cash flow statement | ||
| Cash generated from operations | €23.5M | -€5.1M |
| Net cash from operating activities | €24.5M | -€5.1M |
| Net cash from investing activities | -€613.4K | €1.1M |
| Purchase of PP&E (capex) | €451.4K | €380.1K |
| Net cash from financing activities | -€8.1M | -€6.6M |
| Proceeds from borrowings | €6.2M | €2.4M |
| Repayments of borrowings | €2.9M | €4.7M |
| Lease liability payments | €1.4M | €1.4M |
| Balance sheet | ||
| Total assets | €744.7M | €731.7M |
| Non-current assets | €453.4M | €461.4M |
| Property, plant & equipment | €2.4M | €2.4M |
| Right-of-use assets | €5.1M | €5.6M |
| Current assets | €291.2M | €270.3M |
| Inventories | €207.9M | €205.1M |
| Trade & other receivables | €19.9M | €17.6M |
| Cash & equivalents | €45.3M | €25.2M |
| Total equity | €266.7M | €250.6M |
| — attributable to owners | €263.1M | €247.0M |
| Non-controlling interests | €3.6M | €3.6M |
| Non-current liabilities | €369.0M | €381.5M |
| Long-term borrowings | €83.5M | €87.7M |
| Lease liabilities (non-current) | €11.5M | €13.2M |
| Current liabilities | €109.0M | €99.6M |
| Short-term borrowings | €23.6M | €20.3M |
| Lease liabilities (current) | €1.8M | €1.5M |
| Trade & other payables | €29.3M | €21.2M |
| Deferred tax liabilities | €40.5M | €40.4M |
| Derived metrics | ||
| Free cash flow | €24.0M | -€5.5M |
| Operating margin | 39.1% | 25.3% |
| Net margin | 26.9% | 16.1% |
| Return on equity | 6.5% | 4.2% |
| Cash conversion ratio | 1.41× | -0.49× |
| Capex coverage | 54.24× | -13.54× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €545.8K | €124.4K |
| Adjustments For Decrease Increase In Other Assets | -€552.9K | €4.9M |
| Adjustments For Decrease Increase In Trade and Other Receivables | €571.6K | €1.1M |
| Adjustments For Depreciation Expense | €526.4K | €437.9K |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | €2.9M | €2.8M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | -€188.8K | €41.7K |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | €0 | €305.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | €20.2M | -€7.1M |
| Adjustments For Interest Expense | €4.4M | €4.9M |
| Adjustments For Interest Income | €135.6K | €248.4K |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €14.8M | €2.4M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | €9.1K | €12.2K |
| Basic and Diluted Earnings Loss Per Share | €0.04 | €0.02 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €30.5M | €14.8M |
| Cash Flows From Used In Decrease Increase In Restricted Cash and Cash Equivalents | €26.2M | -€35.8M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €5.0M | €11.9M |
| Comprehensive Income Attributable To Noncontrolling Interests | €68.1K | €334.6K |
| Comprehensive Income Attributable To Owners of Parent | €17.0M | €9.7M |
| Contingent Liabilities Incurred In Relation To Interests In Associates | €3.0M | €2.9M |
| Current Contract Liabilities | €54.0M | €56.3M |
| Current Financial Assets At Fair Value Through Profit Or Loss | €3.5K | €3.5K |
| Current Restricted Cash and Cash Equivalents | €14.3M | €15.9M |
| Current Tax Liabilities Current | €368.9K | €391.5K |
| Depreciation Rightofuse Assets | €618.9K | €618.9K |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €54.8K | €470.0K |
| Dividends Received Classified As Investing Activities | €20.0K | €983.5K |
| Dividends Recognised As Distributions To Noncontrolling Interests | €54.8K | €470.0K |
| Equity and Liabilities | €744.7M | €731.7M |
| Gains Losses On Financial Assets Measured At Fair Value Through Other Comprehensive Income Net of Tax | -€271.5K | -€510.2K |
| Gains Losses On Financial Liabilities At Fair Value Through Profit Or Loss | -€1.5M | -€892.2K |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | -€188.8K | €41.7K |
| Income Taxes Paid Refund Classified As Operating Activities | €0 | €0 |
| Increase Decrease In Cash and Cash Equivalents | €15.7M | -€10.7M |
| Increase Decrease Through Transactions With Owners | -€1.0M | -€710.1K |
| Increase Decrease Through Transfers and Other Changes Equity | — | €16.6K |
| Interest Paid Classified As Financing Activities | €766.6K | €43.4K |
| Interest Received Classified As Investing Activities | €135.6K | €370.8K |
| Investment Accounted For Using Equity Method | €28.7M | €15.0M |
| Investment Property | €378.9M | €375.6M |
| Issued Capital | €72.2M | €72.2M |
| Liabilities | €478.0M | €481.1M |
| Noncurrent Contract Liabilities | €100.0M | €121.8M |
| Noncurrent Financial Assets At Fair Value Through Other Comprehensive Income | €9.0M | €9.3M |
| Noncurrent Payables | €13.5M | €0 |
| Noncurrent Portion of Noncurrent Bonds Issued | €117.0M | €115.5M |
| Noncurrent Receivables | €689.0K | €3.5M |
| Noncurrent Restricted Cash and Cash Equivalents | €13.6M | €38.1M |
| Other Comprehensive Income | -€275.3K | -€517.3K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€275.3K | -€517.3K |
| Other Current Assets | €3.8M | €6.5M |
| Other Gains Losses | €3.5M | €3.4M |
| Other Noncurrent Assets | €15.0M | €11.8M |
| Reserve of Gains and Losses On Financial Assets Measured At Fair Value Through Other Comprehensive Income | €1.2M | €1.4M |
| Retained Earnings | €175.9M | €159.6M |
| Sales and Marketing Expense | €9.8M | €14.5M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€3.8K | -€7.1K |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €14.8M | €2.4M |
| Share Premium | €21.1M | €21.1M |
Methodology
Every line item above is a fact tagged in PANDORA INVESTMENTS PUBLIC LIMITED's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.